Impact of advanced age on survival in patients with implantable cardioverter defibrillators

Europace

Volumn 10, Issue 11, 2008, Pages 1296-1301

  Pellegrini, Cara N ^a   Lee, Keane ^b   Olgin, Jeffrey E ^a   Turakhia, Mintu P ^a   Tseng, Zian H ^a   Lee, Randall ^a   Badhwar, Nitish ^a   Lee, Byron ^a   Varosy, Paul D ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Cardiology Section (111C)   (United States)

Author keywords

Age; Elderly; Implantable cardioverter defibrillator; Mortality; Predictor; Sudden cardiac death

Indexed keywords

ADULT; AGED; AGING; ARTICLE; COMORBIDITY; DEFIBRILLATOR; ELDERLY CARE; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL;

AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; CALIFORNIA; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 55249108029     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun253     Document Type: Article

References (28)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.
2. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-302.
3. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-54.
4. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40.
5. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-90.
6. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
7. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
8. McClellan MB, Tunis SR. Medicare coverage of ICDs. N Engl J Med 2005;352:222-4.
9. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 2005;353:1471-80.
10. Zwanziger J, Hall WJ, Dick AW, Zhao H, Mushlin AI, Hahn RM et al. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 2006;47:2310-8.
11. Grimm W, Flores BT, Marchlinski FE. Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy. Circulation 1993;87:1880-8.
12. Anvari A, Gottsauner-Wolf M, Turel Z, Stix G, Podesser B, Mayer C et al. Predictors of outcome in patients with implantable cardioverter defibrillators. Cardiology 1998;90:180-6.
13. Exner DV, Sheldon RS, Pinski SL, Kron J, Hallstrom A. Do baseline characteristics accurately discriminate between patients likely versus unlikely to benefit from implantable defibrillator therapy? Evaluation of the Canadian implantable defibrillator study implantable cardioverter defibrillatory efficacy score in the antiarrhythmics versus implantable defibrillators trial. Am Heart J 2001;141:99-104.
14. Bloomfield DM, Bigger JT, Steinman RC, Namerow PB, Parides MK, Curtis AB et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 2006;47:456-63.
15. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008;51:288-96.
16. Huang DT, Sesselberg HW, McNitt S, Noyes K, Andrews ML, Hall WJ et al. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy. J Cardiovasc Electrophysiol 2007;18:833-8.
17. Groeneveld PW, Farmer SA, Suh JJ, Matta MA, Yang F. Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly. Heart Rhythm 2008;5:646-53.
18. Panotopoulos PT, Axtell K, Anderson AJ, Sra J, Blanck Z, Deshpande S et al. Efficacy of the implantable cardioverter-defibrillator in the elderly. J Am Coll Cardiol 1997;29:556-60.
19. Trappe HJ, Pfitzner P, Achtelik M, Fieguth HG. Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period. Heart (British Cardiac Society) 1997;78:364-70.
20. Koplan BA, Epstein LM, Albert CM, Stevenson WG. Survival in octogenarians receiving implantable defibrillators. Am Heart J 2006;152:714-9.
21. Geelen P, Lorga Filho A, Primo J, Wellens F, Brugada P. Experience with implantable cardioverter defibrillator therapy in elderly patients. Eur Heart J 1997;18:1339-42.
22. Quan KJ, Lee JH, Costantini O, Konstantakos AK, Murrell HK, Carlson MD et al. Favorable results of implantable cardioverter-defibrillator implantation in patients older than 70 years. Ann Thorac Surg 1997;64:1713-7.
23. Duray G, Richter S, Manegold J, Israel CW, Gronefeld G, Hohnloser SH. Efficacy and safety of ICD therapy in a population of elderly patients treated with optimal background medication. J Interv Card Electrophysiol 2005;14:169-73.
24. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515-26.
25. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982;69:239-41.
26. Lee DS, Tu JV, Austin PC, Dorian P, Yee R, Chong A et al. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol 2007;49:2408-15.
27. Schackman BR, Gold HT, Stone PW, Neumann PJ. How often do sensitivity analyses for economic parameters change cost-utility analysis conclusions? Pharmacoeconomics 2004;22:293-300.
28. Hirth RA, Chernew ME, Miller E, Fendrick AM, Weissert WG. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making 2000;20:332-42.